Reflect on the provided data and tweets to anticipate if the closing price of $jnj is going to increase or decrease at 2017-07-25. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-07-11,0.2,0.4,-0.6,-0.2,-0.2,0.8,1.2,1.9,1.8,1.4,0.9
2017-07-12,-0.1,0.5,-0.3,0.8,0.8,-0.2,0.2,1.0,1.1,0.7,0.3
2017-07-13,0.2,0.3,-0.7,-0.3,-0.3,0.0,0.4,1.2,1.3,1.0,0.6
2017-07-14,-0.5,0.3,-0.6,0.6,0.6,-0.5,-0.2,0.4,0.7,0.5,0.2
2017-07-17,0.4,0.6,-0.3,-0.3,-0.3,-0.1,0.1,0.6,1.0,0.9,0.6
2017-07-18,-2.1,0.4,-2.5,1.7,1.7,-1.3,-1.5,-1.3,-0.7,-0.8,-1.1
2017-07-19,-0.3,0.1,-0.5,0.6,0.6,-1.4,-1.9,-1.8,-1.3,-1.2,-1.5
2017-07-20,-0.6,0.4,-0.7,1.0,1.0,-1.7,-2.6,-2.6,-2.2,-2.1,-2.3
2017-07-21,0.0,0.7,-0.2,-0.9,-0.9,-0.4,-1.5,-1.6,-1.3,-1.1,-1.3
2017-07-24,1.5,1.6,-0.1,-1.7,-1.7,1.4,0.3,0.1,0.3,0.6,0.4

2017-07-11: biggest cancer drugs of 2022 #stocks $pfe, $mrk, $jnj, $bmy, $celg, $abbv |published $jnj estimate on estimize: ... |#medtech #mergers surge again  $stj $abt $jnj $agn $elos $cutr|rt AT_USER ac immune
2017-07-12: rt AT_USER $jnj releasing earnings on 7/18 before open (confirmed). anybody buying/selling in earnings? |AT_USER $tgtx no reason 1101/ibrutinib should not be approved $abbv $jnj #fda -shorts dangerous
2017-07-13: rt AT_USER fda approves j&amp;j's tremfya to treat psoriasis, to cost about $58,100 per patient annually $jnj |#johnsonjohnson j&amp;j's tremfya gets its go-ahead to fight novartis, lilly in psoriasis
2017-07-14: johnson &amp; johnson $jnj expected to announce earnings of $1.79 per share |johnson &amp; johnson $jnj stock rating lowered by bidaskclub |s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bm
2017-07-15: rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt $v $bx $csx $qcom $hog $pgr $cma $swks $ms $ual $amtd    |rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt 
2017-07-16: rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt $v $bx $qcom $hog  via AT_USER |rt AT_USER #earnings $nflx $bac $msft $gs $blk $jnj $ibm $unh $ge $lmt $v $bx $csx $qcom $hog $pg
2017-07-17: rt AT_USER it's going to be a busy week! earnings galore $nflx $blk $bac $jnj $gs $ual $qcom $gww $axp $abt $msft $v $ebay $nue $s¡­|rt AT_USER upcoming #earnings $nflx $bac $gs $jnj $unh $lmt $hog $p
2017-07-18: regent investment management llc has $6.17 million position in johnson &amp; johnson $jnj |regent investment management llc has $6.17 million position in johnson &amp; johnson $jnj |great potential fo
2017-07-19: procter &amp; gamble: let the fun begin  $jnj $mdlz $pg. interesting perspective|johnson &amp; johnson $jnj receives ¡°buy¡± rating from ubs ag |johnson &amp; johnson $jnj issues fy17 earnings guidanc
2017-07-20: johnson &amp;amp; johnson stays healthy in 2q17  $jnj $xlv $pfe $mrk|peoples financial services corp. sells 50 shares of johnson &amp; johnson $jnj |AT_USER thanks for follow! see vista partners #inve
2017-07-21: johnson &amp; johnson $jnj stake boosted by baltimore washington financial advisors inc. |johnson &amp; johnson $jnj now covered by analysts at credit suisse group |credit suisse group begins coverage
2017-07-22: $jnj 6 months in, trump has filled only 27 out of more the 200 envoy posts, mostly... |rt AT_USER btig, atlantic say sell j&amp;j on lackluster drug outlook $jnj |rt AT_USER icymi: 07/21/17 - view tod
2017-07-23: pleased to announce coverage of us stocks. $alrm $amzn $aaoi $ea $jnj $nflx $nke $shop $tsla $v $ma login to see |jt's optimum stock investing daily blog update for 07/24/2017 09:00 am  #dividendstock
2017-07-24: rt AT_USER targeting a $5b brand, samsung and merck launch remicade biosim at 35% discount  $mrk $jnj|s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis
Answer:
Fall